Literature DB >> 2873615

An early phase II clinical trial of remoxipride in schizophrenia with measurement of plasma neuroleptic activity.

G Chouinard, L Turnier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2873615

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  3 in total

1.  Regional distribution and in vivo binding of the atypical antipsychotic drug remoxipride. A biochemical and autoradiographic analysis in the rat brain.

Authors:  C Köhler; A C Radesäter; G Karlsson-Boethius; B Bryske; M Widman
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.

Authors:  J A Den Boer; D P Ravelli; J Huisman; J Ohrvik; W M Verhoeven; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.

Authors:  U Andersson; J E Häggström; M I Nilsson; E Widerlöv
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.